Idaho Health Officials to Adjust Flu Vaccine Plans After National Recommendation Against Nasal Spray

Why it matters locally: The CDC's recommendation against using the nasal spray flu vaccine (LAIV) for the upcoming flu season directly affects Idaho residents, healthcare providers, and public health officials. With a population of nearly two million, Idaho experiences annual flu outbreaks, and vaccination is a crucial prevention strategy. This recommendation means that Idaho's public health districts and medical facilities will need to adjust their flu vaccination plans, ensuring sufficient supplies of injectable flu vaccines (IIV) are available. Parents who typically opt for the nasal spray for their children will need to consider the flu shot option instead, potentially requiring more clinic visits and staff time administering injections.

---

Atlanta, GA – The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted on Wednesday to recommend that the live attenuated influenza vaccine (LAIV), commonly referred to as the nasal spray flu vaccine, not be used during the 2016-2017 influenza season. The decision follows data analysis indicating concerns about the effectiveness of the LAIV. Details surrounding the specific data that prompted the committee's decision were not immediately available in the initial announcement. The ACIP is an advisory group that provides recommendations regarding vaccine use to the CDC. These recommendations are often adopted as public health policy across the United States. Further information outlining the details surrounding the vote and the data leading to the recommendation is expected to be released by the CDC in the near future. The recommendation means that health care providers and public health officials are advised to prioritize the use of other available influenza vaccines, such as the inactivated influenza vaccine (IIV), commonly given as a flu shot, when vaccinating patients against the flu for the 2016-2017 season.